No To Five, Yes To Three: NICE Decides On Funding For Drugs In England

NICE To Review Vyndaqel Guidance Quickly If New Pricing Deal Is Reached

 
• By Neena Brizmohun
  
NICE assesses the cost effectiveness of drugs • Source: Alamy

More from Health Technology Assessment

More from Market Access